Lytix Biopharma: Invitation to the Q3 2026 Results Presentation
Oslo, Norway, November 6, 2026 – Lytix Biopharma ASA (“Lytix” or the “Company”) will release its third quarter 2026 financial results on Friday, November 13, 2026.
Join us for a live webcast presentation featuring CEO Øystein Rekdal, CFO Gjest Breistein and CMO Karim Benhadji where they will discuss the results and provide key insights.
Date: Friday, November 13, 2026
Time: 14:00 CET
Q&A Session:
We welcome your questions in advance. Please send them to post@lytixbiopharma.com, and they will be addressed during the Q&A session following the presentation.
Webcast Details: